Author
Listed:
- Jean Charles Nault
(Inserm, UMR-674, Génomique fonctionnelle des tumeurs solides, IUH
Faculté de Médecine, Labex Immuno-oncology, Université Paris Descartes, Sorbonne Paris Cité)
- Maxime Mallet
(Inserm, UMR-674, Génomique fonctionnelle des tumeurs solides, IUH
Faculté de Médecine, Labex Immuno-oncology, Université Paris Descartes, Sorbonne Paris Cité)
- Camilla Pilati
(Inserm, UMR-674, Génomique fonctionnelle des tumeurs solides, IUH
Faculté de Médecine, Labex Immuno-oncology, Université Paris Descartes, Sorbonne Paris Cité)
- Julien Calderaro
(Inserm, UMR-674, Génomique fonctionnelle des tumeurs solides, IUH
Faculté de Médecine, Labex Immuno-oncology, Université Paris Descartes, Sorbonne Paris Cité
Assistance Publique-Hôpitaux de Paris, CHU Henri Mondor)
- Paulette Bioulac-Sage
(Inserm, UMR-1053, Université Victor Segalen Bordeaux 2
CHU de Bordeaux, Pellegrin Hospital)
- Christophe Laurent
(CHU de Bordeaux, Pellegrin Hospital)
- Alexis Laurent
(Assistance Publique-Hôpitaux de Paris, digestive, CHU Henri Mondor
Inserm, U955)
- Daniel Cherqui
(Assistance Publique-Hôpitaux de Paris, digestive, CHU Henri Mondor
Assistance Publique-Hôpitaux de Paris, Hopital Paul Brousse)
- Charles Balabaud
(Inserm, UMR-1053, Université Victor Segalen Bordeaux 2)
- Jessica Zucman-Rossi
(Inserm, UMR-674, Génomique fonctionnelle des tumeurs solides, IUH
Faculté de Médecine, Labex Immuno-oncology, Université Paris Descartes, Sorbonne Paris Cité
Assistance Publique-Hôpitaux de Paris, Hopital Europeen Georges Pompidou)
Abstract
Somatic mutations activating telomerase reverse-trancriptase promoter were recently identified in several tumour types. Here we identify frequent similar mutations in human hepatocellular carcinomas (59%), cirrhotic preneoplastic macronodules (25%) and hepatocellular adenomas with malignant transformation in hepatocellular carcinomas (44%). In hepatocellular tumours, telomerase reverse-transcripase- and CTNNB1-activating mutations are significantly associated. Moreover, preliminary data suggest that telomerase reverse-trancriptase promoter mutations can increase the expression of telomerase transcript. In conclusion, telomerase reverse-trancriptase promoter mutation is the earliest recurrent genetic event identified in cirrhotic preneoplastic lesions so far and is also the most frequent genetic alteration in hepatocellular carcinomas, arising from both the cirrhotic or non-cirrhotic liver.
Suggested Citation
Jean Charles Nault & Maxime Mallet & Camilla Pilati & Julien Calderaro & Paulette Bioulac-Sage & Christophe Laurent & Alexis Laurent & Daniel Cherqui & Charles Balabaud & Jessica Zucman-Rossi, 2013.
"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions,"
Nature Communications, Nature, vol. 4(1), pages 1-7, October.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3218
DOI: 10.1038/ncomms3218
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Jill Pilet & Theo Z. Hirsch & Barkha Gupta & Amélie Roehrig & Guillaume Morcrette & Aurore Pire & Eric Letouzé & Brice Fresneau & Sophie Taque & Laurence Brugières & Sophie Branchereau & Christophe Ch, 2023.
"Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma,"
Nature Communications, Nature, vol. 14(1), pages 1-14, December.
- Siddharth Narayanan & Marion Dubarry & Conor Lawless & A Peter Banks & Darren J Wilkinson & Simon K Whitehall & David Lydall, 2015.
"Quantitative Fitness Analysis Identifies exo1∆ and Other Suppressors or Enhancers of Telomere Defects in Schizosaccharomyces pombe,"
PLOS ONE, Public Library of Science, vol. 10(7), pages 1-15, July.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3218. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.